Matches in SemOpenAlex for { <https://semopenalex.org/work/W1988850631> ?p ?o ?g. }
Showing items 1 to 70 of
70
with 100 items per page.
- W1988850631 endingPage "327" @default.
- W1988850631 startingPage "326" @default.
- W1988850631 abstract "Back to table of contents Previous article Next article Letter to the EditorFull AccessFemale Sexual Dysfunction and Antidepressant UseTAKESHI TERAO, M.D., PH.D., TAKESHI TERAOSearch for more papers by this author, M.D., PH.D., Oxford, U.K.Published Online:1 Feb 2001https://doi.org/10.1176/appi.ajp.158.2.326-aAboutSectionsView EPUB ToolsAdd to favoritesDownload CitationsTrack Citations ShareShare onFacebookTwitterLinked InEmail To the Editor: David Michelson, M.D., et al. (1) appropriately demonstrated that neither buspirone nor amantadine was more effective than placebo in the treatment of antidepressant-induced sexual dysfunction in women. Their results apparently are not in agreement with those of Landén et al. (2), who showed the superiority of buspirone to placebo for antidepressant-induced sexual dysfunction, particularly in women. However, this discrepancy suggests the possibility that the effects of buspirone on sexual dysfunction might abate with continued treatment, owing to the desensitization of serotonin1A autoreceptors, because Dr. Michelson et al. administered buspirone for a longer period (8 weeks) than Landén et al. (4 weeks).On the other hand, although the study by Dr. Michelson et al. (1) was not primarily aimed at evaluating the efficacy of the combination of fluoxetine and buspirone in treating affective symptoms, I will comment on this issue. Several case studies and open trials showed the efficacy of buspirone added during antidepressant augmentation (3). In the first controlled, double-blind trial (4), however, buspirone augmentation of a selective serotonin reuptake inhibitor (citalopram or paroxetine) in patients with refractory depression failed to demonstrate any difference in efficacy from placebo augmentation.The study of Dr. Michelson et al. (1) seems to be a second such study, although most of their patients were almost recovered, as indicated by their Hamilton depression scale scores. Nonetheless, the results of visual analogue scales measuring mood and energy did not indicate their complete recovery. The fact that amantadine added to fluoxetine significantly improved energy levels and approached statistical significance for mood improvement strongly supports the possibility of at least subjectively insufficient recovery of the patients’ depression at baseline. The mean mood changes in the visual analogue scales from baseline (higher values represent greater improvement) were 8.7 (amantadine added), 1.4 (buspirone added), and 0.6 (placebo added); the mean energy changes were 9.5, 2.1, and –3.2, respectively. There was no difference between the addition of buspirone and the addition of placebo in mood or energy change, although the addition of amantadine was significantly better than the addition of placebo, particularly in energy change. Also, there was no difference among the groups in changes measured by the Beck Depression Inventory. These findings suggest that buspirone added to fluoxetine cannot improve subjective mood or energy in mild depression.Although Dr. Michelson et al. (1) did not mention this suggestion because it was not their purpose, I believe that this is important information to note until further placebo-controlled, double-blind studies clarify the role of buspirone in antidepressant augmentation.References1. Michelson D, Bancroft J, Targum S, Kim Y, Tepner R: Female sexual dysfunction associated with antidepressant administration: a randomized, placebo-controlled study of pharmacologic intervention. Am J Psychiatry 2000; 157:239–243Link, Google Scholar2. Landén M, Eriksson E, Ågren H, Fahlén T: Effect of buspirone on sexual dysfunction in depressed patients treated with selective serotonin reuptake inhibitors. J Clin Psychopharmacol 1999; 19:268–271Crossref, Medline, Google Scholar3. Sussman N: Anxiolytic antidepressant augmentation. J Clin Psychiatry 1998; 59(suppl 5):42–48Google Scholar4. Landén M, Björling G, Ågren H, Fahlén T: A randomized, double-blind, placebo-controlled trial of buspirone in combination with an SSRI in patients with treatment-refractory depression. J Clin Psychiatry 1998; 59:664–668Crossref, Medline, Google Scholar FiguresReferencesCited byDetailsCited byThe Journal of Sexual Medicine, Vol. 7, No. 8Journal of Sex & Marital Therapy, Vol. 33, No. 3Neuropsychopharmacology, Vol. 28, No. 2 Volume 158Issue 2 February 2001Pages 326-a-327 Metrics History Published online 1 February 2001 Published in print 1 February 2001" @default.
- W1988850631 created "2016-06-24" @default.
- W1988850631 creator A5036692814 @default.
- W1988850631 date "2001-02-01" @default.
- W1988850631 modified "2023-10-18" @default.
- W1988850631 title "Female Sexual Dysfunction and Antidepressant Use" @default.
- W1988850631 doi "https://doi.org/10.1176/appi.ajp.158.2.326-a" @default.
- W1988850631 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11156829" @default.
- W1988850631 hasPublicationYear "2001" @default.
- W1988850631 type Work @default.
- W1988850631 sameAs 1988850631 @default.
- W1988850631 citedByCount "3" @default.
- W1988850631 crossrefType "journal-article" @default.
- W1988850631 hasAuthorship W1988850631A5036692814 @default.
- W1988850631 hasConcept C118552586 @default.
- W1988850631 hasConcept C126322002 @default.
- W1988850631 hasConcept C142724271 @default.
- W1988850631 hasConcept C15744967 @default.
- W1988850631 hasConcept C170493617 @default.
- W1988850631 hasConcept C204787440 @default.
- W1988850631 hasConcept C27081682 @default.
- W1988850631 hasConcept C2775864247 @default.
- W1988850631 hasConcept C2776134451 @default.
- W1988850631 hasConcept C2777287423 @default.
- W1988850631 hasConcept C2777828372 @default.
- W1988850631 hasConcept C2778093883 @default.
- W1988850631 hasConcept C2779177272 @default.
- W1988850631 hasConcept C2780764818 @default.
- W1988850631 hasConcept C42219234 @default.
- W1988850631 hasConcept C558461103 @default.
- W1988850631 hasConcept C71924100 @default.
- W1988850631 hasConceptScore W1988850631C118552586 @default.
- W1988850631 hasConceptScore W1988850631C126322002 @default.
- W1988850631 hasConceptScore W1988850631C142724271 @default.
- W1988850631 hasConceptScore W1988850631C15744967 @default.
- W1988850631 hasConceptScore W1988850631C170493617 @default.
- W1988850631 hasConceptScore W1988850631C204787440 @default.
- W1988850631 hasConceptScore W1988850631C27081682 @default.
- W1988850631 hasConceptScore W1988850631C2775864247 @default.
- W1988850631 hasConceptScore W1988850631C2776134451 @default.
- W1988850631 hasConceptScore W1988850631C2777287423 @default.
- W1988850631 hasConceptScore W1988850631C2777828372 @default.
- W1988850631 hasConceptScore W1988850631C2778093883 @default.
- W1988850631 hasConceptScore W1988850631C2779177272 @default.
- W1988850631 hasConceptScore W1988850631C2780764818 @default.
- W1988850631 hasConceptScore W1988850631C42219234 @default.
- W1988850631 hasConceptScore W1988850631C558461103 @default.
- W1988850631 hasConceptScore W1988850631C71924100 @default.
- W1988850631 hasIssue "2" @default.
- W1988850631 hasLocation W19888506311 @default.
- W1988850631 hasLocation W19888506312 @default.
- W1988850631 hasOpenAccess W1988850631 @default.
- W1988850631 hasPrimaryLocation W19888506311 @default.
- W1988850631 hasRelatedWork W1976111096 @default.
- W1988850631 hasRelatedWork W2010221886 @default.
- W1988850631 hasRelatedWork W2018067258 @default.
- W1988850631 hasRelatedWork W2019724922 @default.
- W1988850631 hasRelatedWork W2042433635 @default.
- W1988850631 hasRelatedWork W2053744108 @default.
- W1988850631 hasRelatedWork W2054043813 @default.
- W1988850631 hasRelatedWork W2152069111 @default.
- W1988850631 hasRelatedWork W2255750776 @default.
- W1988850631 hasRelatedWork W2400932514 @default.
- W1988850631 hasVolume "158" @default.
- W1988850631 isParatext "false" @default.
- W1988850631 isRetracted "false" @default.
- W1988850631 magId "1988850631" @default.
- W1988850631 workType "article" @default.